Get the Weekly Intelligence Brief — top committee picks every Sunday.
DOCS · NYSE · STOCK

Doximity (DOCS) Stock Analysis

Healthcare Updated September 05, 2026
$26.34
52W $17.15 – $76.51
59/100
$5.07B
30.4
1.21
AI Committee Verdict
Buy
59/100
Conviction: Contested · 50% agreement · 4 analysts
+12.5%
-6.5%
1.91:1
Contested

Is DOCS Bullish or Bearish?

Bullish. Innellis AI committee rates Doximity (DOCS) Buy with a composite score of 59/100 , based on 4 analysts with 50% agreement. Last updated September 05, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +15.65 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -4.35 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull & Bear Case

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • 2 consecutive earnings misses -- execution concerns — Growth
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of September 05, 2026
Overall Committee Score
59/100
Agreement
50%
Analysts
4
Conviction
Contested
Sector Rank
Top 43%
of 192 Healthcare peers
Growth Analyst neutral
52 / 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− 2 consecutive earnings misses -- execution concerns
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3059.07)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 61.0 to 59.4.

Analyst-level changes:
  • Growth Analyst: score 48->52 (+5).
  • Risk Analyst abstained (was bullish at 80).
  • Value Analyst abstained (was neutral at 54).

Comparing 2026-09-04 to 2026-09-05 (1 day apart).

Technical Analysis

RSI (14)
68.0
Neutral
MACD Histogram
0.037
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$25.32
Resistance
$30.48
Bollinger %B
0.88
Inside Bands
Price vs Moving Averages
EMA 9
$26.16 Above
EMA 21
$25.25 Above
EMA 50
$23.95 Above
EMA 200
$30.24 Below

Fundamental Analysis

Valuation
59
Growth
45
Profitability
100
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio 30.4×
P/B Ratio 5.40×
PEG Ratio -1.06
Dividend Yield 0.00%
52W High $76.51
52W Low $17.15
Quality & Growth
ROE 2061.9%
ROA 1744.7%
Gross Margin 8806.8%
Operating Margin 2960.0%
Revenue Growth YoY
Debt / Equity 0.01
AI Fundamental Assessment
P/E ratio of 30.4 (rich relative to a 15-40x range); Price-to-book of 5.4x; PEG ratio of -1.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 20.6%; Return on assets of 17.4%; Net margin of 25.5%; Gross margin of 88.1%; Current ratio of 6.08 (healthy short-term liquidity); Debt-to-equity of 0.01; Free cash flow per share is positive (1.64); Most recent quarter missed estimates by 6.7%; 2 consecutive earnings misses; EPS growth accelerating (-43.5% -> +11.5% QoQ); Average YoY EPS growth of -19.4%; Analyst estimates falling over recent quarters
Get the Full DOCS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime